The import of pharmaceutical goods to Saudi Arabia exhibited significant fluctuations from 2013 to 2023, with a notable increase from 118.41 million USD in 2013 to 181.91 million USD in 2014, followed by a series of peaks and troughs. In 2023, the import value stood at 150.61 million USD, reflecting a moderate year-on-year increase of 2.34% compared to 2022. Over the past two years, variations displayed a mixed trend with a slight decline in 2022 and a subsequent recovery in 2023. The 5-year CAGR from 2018 to 2023 was calculated at approximately 4.13%, indicating modest growth in recent years.
Forecast data from 2024 to 2028 suggest a steady increase in pharmaceutical imports, with a projected 5-year CAGR of 1.57%, resulting in an anticipated value of 167.09 million USD by 2028. This implies a stable upward trend, albeit at a slower growth rate compared to previous years.
Future trends to watch for include:
-Potential impacts of Saudi Arabia's healthcare reform initiatives on import needs.
-Global pharmaceutical supply chain dynamics and their effects on import costs and availability.
-Continued monitoring of the pharmaceutical market's response to emerging health challenges and technological advancements.
